(Reuters) -Tylenol maker Kenvue said on Monday that Johnson & Johnson will sell its remaining 9.5% stake in the company, ...
Tylenol maker Kenvue said on Monday that Johnson & Johnson will offload its entire 9.5% stake in the company, about a year ...
, opens new tab will sell its remaining 9.5% stake in the company, about a year after the healthcare conglomerate spun off and listed its consumer health business. Based on Kenvue stock's last ...
Tylenol maker Kenvue has said that Johnson & Johnson will sell its remaining 9.5% stake in the company, about a year after the healthcare conglomerate spun off and listed its consumer health business.
Le fabricant de Tylenol Kenvue a déclaré lundi que Johnson & Johnson allait céder la totalité de sa participation de 9,5 % dans la société, environ un an après que le conglomérat de soins ...
Des victimes du cancer poursuivent Johnson & Johnson pour faillites "frauduleuses 22/05 RE Johnson & Johnson se serait engagée dans des faillites de "mauvaise foi" qui ont porté préjudice aux ...